MPL Stock | | | 3.78 0.05 1.31% |
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Change In Working Capital is likely to gain to about 346.7
M in 2024, whereas
Net Invested Capital is likely to drop slightly above 2.1
B in 2024. At this time, Medibank Private's
Interest Expense is comparatively stable compared to the past year.
Depreciation And Amortization is likely to gain to about 93.9
M in 2024, whereas
Income Before Tax is likely to drop slightly above 405.2
M in 2024.
Medibank Private Company Z Score Analysis
Medibank Private's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| First Factor | = | 1.2 * ( | Working Capital | / | Total Assets ) |
|
| Second Factor | = | 1.4 * ( | Retained Earnings | / | Total Assets ) |
|
| Thrid Factor | = | 3.3 * ( | EBITAD | / | Total Assets ) |
|
| Fouth Factor | = | 0.6 * ( | Market Value of Equity | / | Total Liabilities ) |
|
| Fifth Factor | = | 0.99 * ( | Revenue | / | Total Assets ) |
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Based on the company's disclosures, Medibank Private has a Z Score of 0.0. This is 100.0% lower than that of the Insurance sector and about the same as
Financials (which currently averages 0.0) industry. The z score for all Australia stocks is 100.0% higher than that of the company.
| | Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Medibank Private ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medibank Private's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medibank Private's managers, analysts, and investors. Medibank Fundamentals
About Medibank Private Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medibank Private's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medibank Private using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Medibank Private based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Medibank Stock Analysis
When running Medibank Private's price analysis, check to
measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to
predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.